TABLE OF CONENTS
|
| | | | | | |
| | |
Page
|
| |||
Prospectus Supplement | | | | | | | |
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-8 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-14 | | | |
Prospectus | | | | | | | |
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 27 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 27 | | |
Exhibit 107
CALCULATION OF FILING FEE TABLE
424(b)(5)
(Form Type)
Iovance Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Title of Each Class to be Registered |
Fee Calculation Rule |
Amount to Registered(1) |
Proposed Offering Share |
Maximum Aggregate Price |
Fee Rate |
Amount of Registration Fee(2) | |||||||||
Fees to be Paid |
Equity | Common stock, par value $0.000041666 per share |
Rule 457(c) and Rule 457(r) |
— | — | $500,000,000 | $0.00011020 | $55,100 | ||||||||
Fees Previously Paid | — | — | — | — | — | — | — | — | ||||||||
Total Offering Amounts | — | $500,000,000 | — | $55,100 | ||||||||||||
Total Fees Previously Paid | — | — | — | $— | ||||||||||||
Total Fee Offsets | — | — | — | $— | ||||||||||||
Net Fee Due | — | — | — | $55,100 |
(1) | Consists of shares to be issued pursuant to that certain Open Market Sales AgreementSM, or the Sales Agreement, dated November 18, 2022, between Iovance Biotherapeutics, Inc. and Jefferies LLC. |
(2) | Calculated in accordance with Rule 457(c) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the Registration Statement on Form S-3ASR (Registration No. 333-238724). |